SlideShare a Scribd company logo
Ovarian cancer: diagnosisOvarian cancer: diagnosis
and risk assessmentand risk assessment
Noelle Gillette Cloven MDNoelle Gillette Cloven MD
Gynecologic OncologyGynecologic Oncology
Texas Oncology/ Fort WorthTexas Oncology/ Fort Worth
Female Cancer Cases by SiteFemale Cancer Cases by Site
Reprinted by permission of theReprinted by permission of the
American Cancer SocietyAmerican Cancer Society
Female Cancer Deaths by SiteFemale Cancer Deaths by Site
Reprinted by permission of theReprinted by permission of the
American Cancer SocietyAmerican Cancer Society
Ovarian CancerOvarian Cancer
• Most lethal gynecologic cancerMost lethal gynecologic cancer
• Second most common gynecologic cancer in theSecond most common gynecologic cancer in the
USUS
– Responsible for 25,000 cases annuallyResponsible for 25,000 cases annually
– 14,500 deaths annually14,500 deaths annually
• There are 188,000 women living with ovarianThere are 188,000 women living with ovarian
cancer in the United Statescancer in the United States
American Cancer Society
Ovarian cancer vs other femaleOvarian cancer vs other female
cancerscancers
Ovarian Cancer: Stage Distribution and SurvivalOvarian Cancer: Stage Distribution and Survival
StageStage PercentPercent SurvivalSurvival
II 2424 95%95%
IIII 66 65%65%
IIIIII 5555 30%30%
IVIV 1515 15%15%
OverallOverall 50%50%
American Cancer SocietyAmerican Cancer Society
Survival Rates: Ovarian & Breast CancersSurvival Rates: Ovarian & Breast Cancers
Five-Year Survival RatesFive-Year Survival Rates
by Stage at Diagnosisby Stage at Diagnosis
StageStage OvaryOvary BreastBreast
LocalLocal 93%93% 97%97%
RegionalRegional 55%55% 76%76%
DistantDistant 25%25% 21%21%
All StagesAll Stages 50%50% 84%84%
American Cancer Society
Ovarian Cancer: Risk FactorsOvarian Cancer: Risk Factors
Increased Risk Decreased Risk
Age Oral Contraceptive Use
Family history
Pregnancy and
Breastfeeding
Infertility/low parity Tubal ligation
Personal cancer
history
Hysterectomy/Removal
of Both Ovaries
5 Things every woman should5 Things every woman should
know about ovarian cancerknow about ovarian cancer
1) Your personal and family1) Your personal and family
history affect your riskhistory affect your risk
• if your mother,if your mother,
daughter or sister hasdaughter or sister has
ovarian, breast or colonovarian, breast or colon
cancercancer
• age is a strong riskage is a strong risk
factorfactor
• if you are at high risk,if you are at high risk,
there are actions tothere are actions to
take that reduce yourtake that reduce your
risksrisks
Ovarian Cancer: Hereditary RisksOvarian Cancer: Hereditary Risks
Family History of Ovarian Cancer
Lifetime
Risk
None 1.5%
1 first-degree relative 5%
2 first-degree relatives 7%
Hereditary ovarian cancer
syndrome
40%
Known BRCA1 or BRCA2 inherited
mutation
35-65%
Hereditary SyndromesHereditary Syndromes
• Account for 15% of Epithelial OvarianAccount for 15% of Epithelial Ovarian
Cancer ( BRCA, HNPCC)Cancer ( BRCA, HNPCC)
• new genes have been identifiednew genes have been identified
• Inherited from either parentInherited from either parent
• Associated with breast, colon, prostate,Associated with breast, colon, prostate,
pancreatic and endometrial cancerspancreatic and endometrial cancers
Ovarian Cancer: Risk Reduction & PreventionOvarian Cancer: Risk Reduction & Prevention
• Oral contraceptives reduce risk by 50% after 5 orOral contraceptives reduce risk by 50% after 5 or
more years of usemore years of use
• First full-term pregnancy < age 25; number ofFirst full-term pregnancy < age 25; number of
pregnanciespregnancies
• Breast-feedingBreast-feeding
• Hysterectomy/Tubal ligationHysterectomy/Tubal ligation
• Removal of the ovaries and/or fallopian tubesRemoval of the ovaries and/or fallopian tubes
(risk of primary peritoneal cancer remains)(risk of primary peritoneal cancer remains)
2) If you are at high risk, you may2) If you are at high risk, you may
benefit from preventative surgerybenefit from preventative surgery
• removal of tubes andremoval of tubes and
ovariesovaries
• minimally invasiveminimally invasive
surgeriessurgeries
• weigh risks of earlyweigh risks of early
menopausemenopause
• option is screeningoption is screening
with blood tests andwith blood tests and
ultrasoundsultrasounds
3) Ovarian cancer is one of the3) Ovarian cancer is one of the
most diverse kinds of cancermost diverse kinds of cancer
60-70%
15-20%
5-10%
Epithelial Germ Cell Sex Cord Stromal
4) early diagnosis is key, don’t4) early diagnosis is key, don’t
ignore symptomsignore symptoms
• ovarian cancer hasovarian cancer has
been called “silentbeen called “silent
killer”killer”
• symptoms are vaguesymptoms are vague
and mimic moreand mimic more
common conditionscommon conditions
• having a normal PAPhaving a normal PAP
test does not rule outtest does not rule out
ovarian cancerovarian cancer
Ovarian Cancer: SymptomsOvarian Cancer: Symptoms
• 95% of women DO report symptoms95% of women DO report symptoms
• Symptoms can be vague and not gynecologic:Symptoms can be vague and not gynecologic:
– Abdominal bloating, increased girth, pressureAbdominal bloating, increased girth, pressure
– Unusual fatigueUnusual fatigue
– Gastrointestinal disturbances such as nausea,Gastrointestinal disturbances such as nausea,
indigestion, gas, constipation or diarrheaindigestion, gas, constipation or diarrhea
– Urinary frequency or incontinenceUrinary frequency or incontinence
– Abdominal/pelvic painAbdominal/pelvic pain
– Unexplained weight loss or gainUnexplained weight loss or gain
– Shortness of breathShortness of breath
How is Ovarian Cancer Diagnosed?How is Ovarian Cancer Diagnosed?
• Vaginal - rectal examVaginal - rectal exam
• Transvaginal ultrasoundTransvaginal ultrasound
• CA 125 blood testCA 125 blood test
• If indicatedIf indicated, surgery and study of tumor tissue, surgery and study of tumor tissue
5) The type of doctor that you see5) The type of doctor that you see
affects outcomeaffects outcome
• studies show betterstudies show better
survival in patientssurvival in patients
who receive care by awho receive care by a
gynecologic oncologistgynecologic oncologist
• ““high volumehigh volume
hospitals” also havehospitals” also have
better outcomesbetter outcomes
What is a GynecologicWhat is a Gynecologic
OncologistOncologist??
• Obstetrician/gynecologists who specialize inObstetrician/gynecologists who specialize in
treating women with reproductive tracttreating women with reproductive tract
cancerscancers
• Comprehensive management of gynecologicComprehensive management of gynecologic
cancers, including:cancers, including:
– Surgery, radiation therapy, chemotherapySurgery, radiation therapy, chemotherapy
and experimental treatmentsand experimental treatments
The Importance of Specialty CareThe Importance of Specialty Care
• Gynecologic oncologists are 5 times more likelyGynecologic oncologists are 5 times more likely
to completely remove ovarian tumorsto completely remove ovarian tumors
• 80% of ovarian cancer patients receive inadequate80% of ovarian cancer patients receive inadequate
surgical staging fromsurgical staging from
non-gynecologic oncologist surgeonsnon-gynecologic oncologist surgeons
• Survival outcomes vastly improved with gynecologicSurvival outcomes vastly improved with gynecologic
oncologistsoncologists
Ovarian Cancer: TheOvarian Cancer: The
Importance of StagingImportance of Staging
• Accurate staging is essential for physiciansAccurate staging is essential for physicians
to know what course of treatment will beto know what course of treatment will be
most effective.most effective.
Ovarian Cancer: How is OvarianOvarian Cancer: How is Ovarian
Cancer Treated?Cancer Treated?
Standard:Standard:
• Surgical staging (preferably by a gynecologicSurgical staging (preferably by a gynecologic
oncologist)oncologist)
• Chemotherapy for most patients (For example,Chemotherapy for most patients (For example,
platinum/Taxane chemotherapy)platinum/Taxane chemotherapy)
• Radiation therapy when appropriateRadiation therapy when appropriate
• Clinical trialsClinical trials
Ovarian Cancer: Take ActionOvarian Cancer: Take Action
• Define your riskDefine your risk
– Discuss regular monitoring with physicianDiscuss regular monitoring with physician
• If symptoms persist and are unusual for youIf symptoms persist and are unusual for you
– See a doctorSee a doctor
• If ovarian cancer is suspected or diagnosedIf ovarian cancer is suspected or diagnosed
– Insist on being referred to a gynecologicInsist on being referred to a gynecologic
oncologistoncologist
Share this information!Share this information!
Ovarian Cancer: Future DirectionsOvarian Cancer: Future Directions
• Effective screening testsEffective screening tests
• Early detectionEarly detection
• PreventionPrevention
• Overcoming chemoresistanceOvercoming chemoresistance
• Targeted therapy (angiogenesis, PARP)Targeted therapy (angiogenesis, PARP)
• Strengthening education effortsStrengthening education efforts
• Individualized confidential gynecologicIndividualized confidential gynecologic
(ovarian, endometrial, cervical) and breast cancer ris(ovarian, endometrial, cervical) and breast cancer ris
assessmentassessment
• SGO/GCF member directory by name/stateSGO/GCF member directory by name/state
• Daily newsfeedDaily newsfeed
• Links to otherLinks to other
sources of cancersources of cancer
informationinformation
• BookstoreBookstore
Women’s Cancer Network: www.wcn.orgWomen’s Cancer Network: www.wcn.org
All Women
HPV and Cervical CancerHPV and Cervical Cancer
About 80% of Women
will be infected with
HPV in their lifetime
HPV and Cervical CancerHPV and Cervical Cancer
About 7% of
Women will have
an abnormal
Pap test
HPV and Cervical CancerHPV and Cervical Cancer
300,000 Women
(per year in the
United States) will
have a high grade
precancerous
lesions
HPV and Cervical CancerHPV and Cervical Cancer
About 10,000
Women (per year
in the United
States) will
develop cervical
cancer
HPV and Cervical CancerHPV and Cervical Cancer

More Related Content

What's hot

Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15
Basalama Ali
 
Epidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 apEpidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 ap
letymbou
 
Fact of the Day: Ovarian Cancer Awareness Month
Fact of the Day: Ovarian Cancer Awareness MonthFact of the Day: Ovarian Cancer Awareness Month
Fact of the Day: Ovarian Cancer Awareness Month
MyriadGenetics
 
Screening in carcinoma breast
Screening in carcinoma breast Screening in carcinoma breast
Screening in carcinoma breast
pgclubrcc
 
CERVIX CANCER IN NUTSHELL
CERVIX CANCER IN NUTSHELLCERVIX CANCER IN NUTSHELL
CERVIX CANCER IN NUTSHELL
Kanhu Charan
 
WOMEN CANCER AWARENESS
WOMEN CANCER AWARENESSWOMEN CANCER AWARENESS
WOMEN CANCER AWARENESS
Kanhu Charan
 
Mammography Screening
Mammography ScreeningMammography Screening
Mammography Screening
DES Daughter
 
endocrine therapy for breast cancers
endocrine therapy for breast cancersendocrine therapy for breast cancers
endocrine therapy for breast cancers
Gebrekirstos Hagos Gebrekirstos, MD
 
Breast Cancer Screening
Breast Cancer ScreeningBreast Cancer Screening
Breast Cancer ScreeningAsha Reddy
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
Ovarian cancer screening
Ovarian cancer screening Ovarian cancer screening
Ovarian cancer screening
Niranjan Chavan
 
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...
Alok Gupta
 
Breast cancer screening dr.ayman jafar
Breast cancer screening dr.ayman jafarBreast cancer screening dr.ayman jafar
Breast cancer screening dr.ayman jafar
Ayman Jafar
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
National Ovarian Cancer Coalition
 
Breast cancer screening
Breast cancer screeningBreast cancer screening
Breast cancer screening
BIJAPUROBG
 
Breast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tongBreast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tong
jim kuok
 

What's hot (20)

Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15
 
Cancer Screening
Cancer ScreeningCancer Screening
Cancer Screening
 
Epidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 apEpidemiology of breast cancer 2014 ap
Epidemiology of breast cancer 2014 ap
 
Fact of the Day: Ovarian Cancer Awareness Month
Fact of the Day: Ovarian Cancer Awareness MonthFact of the Day: Ovarian Cancer Awareness Month
Fact of the Day: Ovarian Cancer Awareness Month
 
Screening in carcinoma breast
Screening in carcinoma breast Screening in carcinoma breast
Screening in carcinoma breast
 
Breast Cancer
Breast CancerBreast Cancer
Breast Cancer
 
CERVIX CANCER IN NUTSHELL
CERVIX CANCER IN NUTSHELLCERVIX CANCER IN NUTSHELL
CERVIX CANCER IN NUTSHELL
 
WOMEN CANCER AWARENESS
WOMEN CANCER AWARENESSWOMEN CANCER AWARENESS
WOMEN CANCER AWARENESS
 
Breast Cancer Screening Presentation - PiPP
Breast Cancer Screening Presentation - PiPPBreast Cancer Screening Presentation - PiPP
Breast Cancer Screening Presentation - PiPP
 
Mammography Screening
Mammography ScreeningMammography Screening
Mammography Screening
 
endocrine therapy for breast cancers
endocrine therapy for breast cancersendocrine therapy for breast cancers
endocrine therapy for breast cancers
 
Breast Cancer Screening
Breast Cancer ScreeningBreast Cancer Screening
Breast Cancer Screening
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
prevention Cervical cancer
prevention Cervical cancerprevention Cervical cancer
prevention Cervical cancer
 
Ovarian cancer screening
Ovarian cancer screening Ovarian cancer screening
Ovarian cancer screening
 
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...
 
Breast cancer screening dr.ayman jafar
Breast cancer screening dr.ayman jafarBreast cancer screening dr.ayman jafar
Breast cancer screening dr.ayman jafar
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
 
Breast cancer screening
Breast cancer screeningBreast cancer screening
Breast cancer screening
 
Breast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tongBreast cancer screening-2021 chan hio tong
Breast cancer screening-2021 chan hio tong
 

Similar to Tcu 2014

Women cancer
Women cancerWomen cancer
Women cancer
Kartik Bhatpalliwar
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
vandana bansal
 
Ganz 2 13-13
Ganz 2 13-13Ganz 2 13-13
Ganz 2 13-13i-ACT
 
Hereditary Cancer Predisposition
Hereditary Cancer PredispositionHereditary Cancer Predisposition
screening of cancers
screening of cancersscreening of cancers
screening of cancers
Shodhan Patel
 
Cervical Malignancy.pptx
Cervical Malignancy.pptxCervical Malignancy.pptx
Cervical Malignancy.pptx
Dr. Indranil Bhattacharya
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness drmcbansal
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awarenessdrmcbansal
 
Breast cancer screening, medical, epidemiologic, social and psychologic aspects
Breast cancer screening, medical, epidemiologic, social and psychologic aspectsBreast cancer screening, medical, epidemiologic, social and psychologic aspects
Breast cancer screening, medical, epidemiologic, social and psychologic aspects
Cancer Rose
 
Beyond Cervical Cancer: What You Need to Know About HPV.pptx
Beyond Cervical Cancer: What You Need to Know About HPV.pptxBeyond Cervical Cancer: What You Need to Know About HPV.pptx
Beyond Cervical Cancer: What You Need to Know About HPV.pptx
bkling
 
Malignancy of ovary
Malignancy of ovaryMalignancy of ovary
Malignancy of ovarydrmcbansal
 
An apporach to ovarian pathology
An apporach to ovarian pathologyAn apporach to ovarian pathology
An apporach to ovarian pathology
Milan Silwal
 
CERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTIONCERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTION
O. E.Nyandi PhD
 
March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...
March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...
March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...
Fight Colorectal Cancer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
Ziyad Salih
 
asmi gyn.pptx about ovarian cancer gynaecology
asmi gyn.pptx about ovarian cancer gynaecologyasmi gyn.pptx about ovarian cancer gynaecology
asmi gyn.pptx about ovarian cancer gynaecology
Asmitajha12
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometrium
Satyajeet Rath
 
cervical and ovarian cancer study: a review
cervical and ovarian cancer study: a reviewcervical and ovarian cancer study: a review
cervical and ovarian cancer study: a review
AYODEJI BLESSING AJILEYE
 

Similar to Tcu 2014 (20)

Women cancer
Women cancerWomen cancer
Women cancer
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
 
Ganz 2 13-13
Ganz 2 13-13Ganz 2 13-13
Ganz 2 13-13
 
Hereditary Cancer Predisposition
Hereditary Cancer PredispositionHereditary Cancer Predisposition
Hereditary Cancer Predisposition
 
screening of cancers
screening of cancersscreening of cancers
screening of cancers
 
Cervical Malignancy.pptx
Cervical Malignancy.pptxCervical Malignancy.pptx
Cervical Malignancy.pptx
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awareness
 
Cervical cancer ppt
Cervical cancer pptCervical cancer ppt
Cervical cancer ppt
 
Breast cancer screening, medical, epidemiologic, social and psychologic aspects
Breast cancer screening, medical, epidemiologic, social and psychologic aspectsBreast cancer screening, medical, epidemiologic, social and psychologic aspects
Breast cancer screening, medical, epidemiologic, social and psychologic aspects
 
Beyond Cervical Cancer: What You Need to Know About HPV.pptx
Beyond Cervical Cancer: What You Need to Know About HPV.pptxBeyond Cervical Cancer: What You Need to Know About HPV.pptx
Beyond Cervical Cancer: What You Need to Know About HPV.pptx
 
Malignancy of ovary
Malignancy of ovaryMalignancy of ovary
Malignancy of ovary
 
An apporach to ovarian pathology
An apporach to ovarian pathologyAn apporach to ovarian pathology
An apporach to ovarian pathology
 
CERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTIONCERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTION
 
March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...
March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...
March 2019 - Polyps and Prevention: The Importance of Screening for Colorecta...
 
Adnexal mass kauh
Adnexal mass kauhAdnexal mass kauh
Adnexal mass kauh
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
asmi gyn.pptx about ovarian cancer gynaecology
asmi gyn.pptx about ovarian cancer gynaecologyasmi gyn.pptx about ovarian cancer gynaecology
asmi gyn.pptx about ovarian cancer gynaecology
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometrium
 
cervical and ovarian cancer study: a review
cervical and ovarian cancer study: a reviewcervical and ovarian cancer study: a review
cervical and ovarian cancer study: a review
 

Recently uploaded

Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 

Tcu 2014

  • 1. Ovarian cancer: diagnosisOvarian cancer: diagnosis and risk assessmentand risk assessment Noelle Gillette Cloven MDNoelle Gillette Cloven MD Gynecologic OncologyGynecologic Oncology Texas Oncology/ Fort WorthTexas Oncology/ Fort Worth
  • 2. Female Cancer Cases by SiteFemale Cancer Cases by Site Reprinted by permission of theReprinted by permission of the American Cancer SocietyAmerican Cancer Society
  • 3. Female Cancer Deaths by SiteFemale Cancer Deaths by Site Reprinted by permission of theReprinted by permission of the American Cancer SocietyAmerican Cancer Society
  • 4. Ovarian CancerOvarian Cancer • Most lethal gynecologic cancerMost lethal gynecologic cancer • Second most common gynecologic cancer in theSecond most common gynecologic cancer in the USUS – Responsible for 25,000 cases annuallyResponsible for 25,000 cases annually – 14,500 deaths annually14,500 deaths annually • There are 188,000 women living with ovarianThere are 188,000 women living with ovarian cancer in the United Statescancer in the United States American Cancer Society
  • 5. Ovarian cancer vs other femaleOvarian cancer vs other female cancerscancers
  • 6. Ovarian Cancer: Stage Distribution and SurvivalOvarian Cancer: Stage Distribution and Survival StageStage PercentPercent SurvivalSurvival II 2424 95%95% IIII 66 65%65% IIIIII 5555 30%30% IVIV 1515 15%15% OverallOverall 50%50% American Cancer SocietyAmerican Cancer Society
  • 7. Survival Rates: Ovarian & Breast CancersSurvival Rates: Ovarian & Breast Cancers Five-Year Survival RatesFive-Year Survival Rates by Stage at Diagnosisby Stage at Diagnosis StageStage OvaryOvary BreastBreast LocalLocal 93%93% 97%97% RegionalRegional 55%55% 76%76% DistantDistant 25%25% 21%21% All StagesAll Stages 50%50% 84%84% American Cancer Society
  • 8. Ovarian Cancer: Risk FactorsOvarian Cancer: Risk Factors Increased Risk Decreased Risk Age Oral Contraceptive Use Family history Pregnancy and Breastfeeding Infertility/low parity Tubal ligation Personal cancer history Hysterectomy/Removal of Both Ovaries
  • 9. 5 Things every woman should5 Things every woman should know about ovarian cancerknow about ovarian cancer
  • 10. 1) Your personal and family1) Your personal and family history affect your riskhistory affect your risk • if your mother,if your mother, daughter or sister hasdaughter or sister has ovarian, breast or colonovarian, breast or colon cancercancer • age is a strong riskage is a strong risk factorfactor • if you are at high risk,if you are at high risk, there are actions tothere are actions to take that reduce yourtake that reduce your risksrisks
  • 11. Ovarian Cancer: Hereditary RisksOvarian Cancer: Hereditary Risks Family History of Ovarian Cancer Lifetime Risk None 1.5% 1 first-degree relative 5% 2 first-degree relatives 7% Hereditary ovarian cancer syndrome 40% Known BRCA1 or BRCA2 inherited mutation 35-65%
  • 12. Hereditary SyndromesHereditary Syndromes • Account for 15% of Epithelial OvarianAccount for 15% of Epithelial Ovarian Cancer ( BRCA, HNPCC)Cancer ( BRCA, HNPCC) • new genes have been identifiednew genes have been identified • Inherited from either parentInherited from either parent • Associated with breast, colon, prostate,Associated with breast, colon, prostate, pancreatic and endometrial cancerspancreatic and endometrial cancers
  • 13. Ovarian Cancer: Risk Reduction & PreventionOvarian Cancer: Risk Reduction & Prevention • Oral contraceptives reduce risk by 50% after 5 orOral contraceptives reduce risk by 50% after 5 or more years of usemore years of use • First full-term pregnancy < age 25; number ofFirst full-term pregnancy < age 25; number of pregnanciespregnancies • Breast-feedingBreast-feeding • Hysterectomy/Tubal ligationHysterectomy/Tubal ligation • Removal of the ovaries and/or fallopian tubesRemoval of the ovaries and/or fallopian tubes (risk of primary peritoneal cancer remains)(risk of primary peritoneal cancer remains)
  • 14. 2) If you are at high risk, you may2) If you are at high risk, you may benefit from preventative surgerybenefit from preventative surgery • removal of tubes andremoval of tubes and ovariesovaries • minimally invasiveminimally invasive surgeriessurgeries • weigh risks of earlyweigh risks of early menopausemenopause • option is screeningoption is screening with blood tests andwith blood tests and ultrasoundsultrasounds
  • 15.
  • 16. 3) Ovarian cancer is one of the3) Ovarian cancer is one of the most diverse kinds of cancermost diverse kinds of cancer 60-70% 15-20% 5-10% Epithelial Germ Cell Sex Cord Stromal
  • 17. 4) early diagnosis is key, don’t4) early diagnosis is key, don’t ignore symptomsignore symptoms • ovarian cancer hasovarian cancer has been called “silentbeen called “silent killer”killer” • symptoms are vaguesymptoms are vague and mimic moreand mimic more common conditionscommon conditions • having a normal PAPhaving a normal PAP test does not rule outtest does not rule out ovarian cancerovarian cancer
  • 18. Ovarian Cancer: SymptomsOvarian Cancer: Symptoms • 95% of women DO report symptoms95% of women DO report symptoms • Symptoms can be vague and not gynecologic:Symptoms can be vague and not gynecologic: – Abdominal bloating, increased girth, pressureAbdominal bloating, increased girth, pressure – Unusual fatigueUnusual fatigue – Gastrointestinal disturbances such as nausea,Gastrointestinal disturbances such as nausea, indigestion, gas, constipation or diarrheaindigestion, gas, constipation or diarrhea – Urinary frequency or incontinenceUrinary frequency or incontinence – Abdominal/pelvic painAbdominal/pelvic pain – Unexplained weight loss or gainUnexplained weight loss or gain – Shortness of breathShortness of breath
  • 19. How is Ovarian Cancer Diagnosed?How is Ovarian Cancer Diagnosed? • Vaginal - rectal examVaginal - rectal exam • Transvaginal ultrasoundTransvaginal ultrasound • CA 125 blood testCA 125 blood test • If indicatedIf indicated, surgery and study of tumor tissue, surgery and study of tumor tissue
  • 20. 5) The type of doctor that you see5) The type of doctor that you see affects outcomeaffects outcome • studies show betterstudies show better survival in patientssurvival in patients who receive care by awho receive care by a gynecologic oncologistgynecologic oncologist • ““high volumehigh volume hospitals” also havehospitals” also have better outcomesbetter outcomes
  • 21. What is a GynecologicWhat is a Gynecologic OncologistOncologist?? • Obstetrician/gynecologists who specialize inObstetrician/gynecologists who specialize in treating women with reproductive tracttreating women with reproductive tract cancerscancers • Comprehensive management of gynecologicComprehensive management of gynecologic cancers, including:cancers, including: – Surgery, radiation therapy, chemotherapySurgery, radiation therapy, chemotherapy and experimental treatmentsand experimental treatments
  • 22. The Importance of Specialty CareThe Importance of Specialty Care • Gynecologic oncologists are 5 times more likelyGynecologic oncologists are 5 times more likely to completely remove ovarian tumorsto completely remove ovarian tumors • 80% of ovarian cancer patients receive inadequate80% of ovarian cancer patients receive inadequate surgical staging fromsurgical staging from non-gynecologic oncologist surgeonsnon-gynecologic oncologist surgeons • Survival outcomes vastly improved with gynecologicSurvival outcomes vastly improved with gynecologic oncologistsoncologists
  • 23. Ovarian Cancer: TheOvarian Cancer: The Importance of StagingImportance of Staging • Accurate staging is essential for physiciansAccurate staging is essential for physicians to know what course of treatment will beto know what course of treatment will be most effective.most effective.
  • 24. Ovarian Cancer: How is OvarianOvarian Cancer: How is Ovarian Cancer Treated?Cancer Treated? Standard:Standard: • Surgical staging (preferably by a gynecologicSurgical staging (preferably by a gynecologic oncologist)oncologist) • Chemotherapy for most patients (For example,Chemotherapy for most patients (For example, platinum/Taxane chemotherapy)platinum/Taxane chemotherapy) • Radiation therapy when appropriateRadiation therapy when appropriate • Clinical trialsClinical trials
  • 25. Ovarian Cancer: Take ActionOvarian Cancer: Take Action • Define your riskDefine your risk – Discuss regular monitoring with physicianDiscuss regular monitoring with physician • If symptoms persist and are unusual for youIf symptoms persist and are unusual for you – See a doctorSee a doctor • If ovarian cancer is suspected or diagnosedIf ovarian cancer is suspected or diagnosed – Insist on being referred to a gynecologicInsist on being referred to a gynecologic oncologistoncologist Share this information!Share this information!
  • 26. Ovarian Cancer: Future DirectionsOvarian Cancer: Future Directions • Effective screening testsEffective screening tests • Early detectionEarly detection • PreventionPrevention • Overcoming chemoresistanceOvercoming chemoresistance • Targeted therapy (angiogenesis, PARP)Targeted therapy (angiogenesis, PARP) • Strengthening education effortsStrengthening education efforts
  • 27. • Individualized confidential gynecologicIndividualized confidential gynecologic (ovarian, endometrial, cervical) and breast cancer ris(ovarian, endometrial, cervical) and breast cancer ris assessmentassessment • SGO/GCF member directory by name/stateSGO/GCF member directory by name/state • Daily newsfeedDaily newsfeed • Links to otherLinks to other sources of cancersources of cancer informationinformation • BookstoreBookstore Women’s Cancer Network: www.wcn.orgWomen’s Cancer Network: www.wcn.org
  • 28.
  • 29. All Women HPV and Cervical CancerHPV and Cervical Cancer
  • 30. About 80% of Women will be infected with HPV in their lifetime HPV and Cervical CancerHPV and Cervical Cancer
  • 31. About 7% of Women will have an abnormal Pap test HPV and Cervical CancerHPV and Cervical Cancer
  • 32. 300,000 Women (per year in the United States) will have a high grade precancerous lesions HPV and Cervical CancerHPV and Cervical Cancer
  • 33. About 10,000 Women (per year in the United States) will develop cervical cancer HPV and Cervical CancerHPV and Cervical Cancer